This is a news story, published by University of Cambridge, that relates primarily to the University of Cambridge news.
For more biology news, you can click here:
more biology newsFor more news from University of Cambridge, you can click here:
more news from University of CambridgeOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best science news, business news, entertainment news, and much more. If you like biology news, you might also like this article about
whole immune system. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest immune suppression news, immune response news, biology news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
severe immune responseUniversity of Cambridge
•75% Informative
Scientists at the University of Cambridge have discovered that a type of white blood cell - called a regulatory T cell - exists as a single large population of cells that constantly move throughout the body looking for, and repairing, damaged tissue.
This overturns the traditional thinking that regulatory T cells exist as multiple specialist populations that are restricted to specific parts of the body.
Finding has implications for the treatment of many different diseases because almost all diseases and injuries trigger the body’s immune system.
A single large population of healer cells, called regulatory T cells, is whizzing around our body.
These cells shut down inflammation and repair the collateral damage to cells caused after our immune system has responded to injury or illness.
Current anti-inflammatory drugs used for this purpose suppress the body’s whole immune system.
Discovery could lead to more targeted treatments, with fewer side-effects, for issues from lengthy COVID infections to autoimmune diseases like multiple sclerosis.
Clinical trials in humans are now planned.
VR Score
71
Informative language
67
Neutral language
64
Article tone
informal
Language
English
Language complexity
57
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
long-living
External references
1
Source diversity
1
Affiliate links
no affiliate links